Healthy men needed for first human test of new acromegaly drug
NCT ID NCT07195175
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 20 times
Summary
This early-stage study tests whether MAR002 is safe and tolerable in healthy men. It is the first time this drug is given to humans. The study involves 45 healthy men aged 18-40 who will receive either MAR002 or a placebo. The goal is to check for side effects and how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Marea Site
RECRUITINGTempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.